MESOBLAST LTD revenue breakdown overview

MESOBLAST LTD revenue for the last year amounted to 6.72 M CHF, the most of which — 6.65 M CHF — came from its highest performing source at the moment, Adult Stem Cell Technology, the year earlier bringing 9.29 M CHF. The greatest contribution to the revenue figure was made by Australia, United States and Singapore — last year it brought MESOBLAST LTD 6.65 M CHF, and the year before that — 9.29 M CHF.